{"id":3,"date":"2023-09-29T08:40:58","date_gmt":"2023-09-29T06:40:58","guid":{"rendered":"https:\/\/webs.uab.cat\/innovative-biodrugs\/?p=3"},"modified":"2023-09-29T09:19:24","modified_gmt":"2023-09-29T07:19:24","slug":"innovative-biodrugs-2021-sgr00092","status":"publish","type":"post","link":"https:\/\/webs.uab.cat\/innovative-biodrugs\/2023\/09\/29\/innovative-biodrugs-2021-sgr00092\/","title":{"rendered":"INNOVATIVE BIODRUGS (2021 SGR00092)"},"content":{"rendered":"\n<p class=\"has-normal-font-size wp-block-paragraph\">The team&nbsp;is efficiently organized into three&nbsp;Technological&nbsp;Units (namely the <strong>Nanopharmacology&nbsp;Unit<\/strong>, the <strong>Protein Drug&nbsp;Unit<\/strong>&nbsp;and the <strong>Bacteriology&nbsp;Unit<\/strong>), that perform collaborative activities and basic and applied research in drug design. We pay a special attention to nanomedical areas but also considering protein-drugs, whole-cell drugs and chemical drugs using unconventional mechanisms of action. In this context, our research lines explore&nbsp;novel concepts and biomedical approaches for the generation of innovative drugs, vaccines and immunomodulators for tailoring and use in a rather broad&nbsp;set of clinical conditions, including&nbsp;cancer, rare diseases, infectious diseases&nbsp;and veterinary medicine.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The team&nbsp;is efficiently organized into three&nbsp;Technological&nbsp;Units (namely the Nanopharmacology&nbsp;Unit, the Protein Drug&nbsp;Unit&nbsp;and the Bacteriology&nbsp;Unit), that perform collaborative activities and basic and applied research in drug design. We pay a special attention to nanomedical areas but also considering protein-drugs, whole-cell drugs and chemical drugs using unconventional mechanisms of action. In this context, our research lines explore&nbsp;novel [&hellip;]<\/p>\n","protected":false},"author":2094,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":true,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3","post","type-post","status-publish","format-standard","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/webs.uab.cat\/innovative-biodrugs\/wp-json\/wp\/v2\/posts\/3","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/webs.uab.cat\/innovative-biodrugs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/webs.uab.cat\/innovative-biodrugs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/webs.uab.cat\/innovative-biodrugs\/wp-json\/wp\/v2\/users\/2094"}],"replies":[{"embeddable":true,"href":"https:\/\/webs.uab.cat\/innovative-biodrugs\/wp-json\/wp\/v2\/comments?post=3"}],"version-history":[{"count":4,"href":"https:\/\/webs.uab.cat\/innovative-biodrugs\/wp-json\/wp\/v2\/posts\/3\/revisions"}],"predecessor-version":[{"id":75,"href":"https:\/\/webs.uab.cat\/innovative-biodrugs\/wp-json\/wp\/v2\/posts\/3\/revisions\/75"}],"wp:attachment":[{"href":"https:\/\/webs.uab.cat\/innovative-biodrugs\/wp-json\/wp\/v2\/media?parent=3"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/webs.uab.cat\/innovative-biodrugs\/wp-json\/wp\/v2\/categories?post=3"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/webs.uab.cat\/innovative-biodrugs\/wp-json\/wp\/v2\/tags?post=3"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}